Looking for a deal in your backyard? The NIH is the world’s largest investor in early stage life sciences companies. Over 1000 companies annually tap into NIH’s SBIR and STTR program for nondilutive funding to the tune of $980M in FY17. Did you know the NIH maintains RePORTER, an online database, of all funded companies and projects?
{iframe}https://www.angelcapitalassociation.org/blog/tapping-into-americas-biomedical-seed-fund/{/iframe}